Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Br J Haematol

Retrieve available abstracts of 293 articles:
HTML format



Single Articles


    December 2022
  1. LI M, Liu L, Ding B, Song X, et al
    Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib.
    Br J Haematol. 2022;199:e37-e42.
    PubMed    


  2. WINER JC, Yee ME, Ataga KI, Lebensburger JD, et al
    Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.
    Br J Haematol. 2022;199:e43-e47.
    PubMed    


  3. DE LA IGLESIA INIGO S, Navarrete Bullon L, Stuckey R, Veiga Vaz A, et al
    Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion-dependent thalassemia patient following treatment with luspatercept: A case report.
    Br J Haematol. 2022;199:e30-e33.
    PubMed    


  4. RAJPUT RV, Ma X, Boswell KL, Gaudinski M, et al
    Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
    Br J Haematol. 2022;199:679-687.
    PubMed     Abstract available


  5. CONNELLY JA, Savani BN
    Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
    Br J Haematol. 2022;199:639-641.
    PubMed     Abstract available


  6. VIAL Y, Lainey E, Leblanc T, Baudouin V, et al
    De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.
    Br J Haematol. 2022;199:739-743.
    PubMed     Abstract available


    November 2022
  7. AMPOMAH MA, Drake JA, Anum A, Amponsah B, et al
    A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana.
    Br J Haematol. 2022;199:411-426.
    PubMed     Abstract available


  8. XU L, Lu Y, Hu S, Li C, et al
    Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.
    Br J Haematol. 2022;199:401-410.
    PubMed     Abstract available


  9. HAN J, Zhang X, Molokie RE, Njoku FU, et al
    COVID-19 vaccination status and disease burden in patients with sickle cell disease.
    Br J Haematol. 2022;199:e21-e24.
    PubMed    


  10. OGUNSILE FJ, Stewart KJ, Kanter J, Lanzkron SM, et al
    An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease.
    Br J Haematol. 2022;199:597-602.
    PubMed     Abstract available


  11. RODRIGUEZ CORTE J, Candal-Pedreira C, Ruano-Ravina A, Perez-Rios M, et al
    Home-based blood transfusion therapy: A systematic review.
    Br J Haematol. 2022;199:496-506.
    PubMed     Abstract available


    October 2022
  12. TORTI L
    Life beyond alpha-thalassaemia: We are moving forward.
    Br J Haematol. 2022;199:11-13.
    PubMed     Abstract available


  13. PAALVAST Y, Moazzen S, Sweegers M, Hogema B, et al
    A computational model for prediction of ferritin and haemoglobin levels in blood donors.
    Br J Haematol. 2022;199:143-152.
    PubMed     Abstract available


  14. CONRAN N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, et al
    Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
    Br J Haematol. 2022;199:153-157.
    PubMed    


  15. AKE-SITTIPAISARN S, Sirichotiyakul S, Srisupundit K, Luewan S, et al
    Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study.
    Br J Haematol. 2022;199:122-129.
    PubMed     Abstract available


  16. EYSSETTE-GUERREAU S, Khimoud D, Michaux K, Odievre MH, et al
    Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
    Br J Haematol. 2022;199:e8-e11.
    PubMed    


  17. ESPERTI S, Boisson C, Robert M, Nader E, et al
    Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia?
    Br J Haematol. 2022;199:289-291.
    PubMed    


  18. QUARELLO P, Ramenghi U, Fagioli F
    Diamond-Blackfan anaemia with iron overload: A serious issue.
    Br J Haematol. 2022;199:171-172.
    PubMed     Abstract available


  19. CHURCHILL D, Ali H, Moussa M, Donohue C, et al
    Maternal iron deficiency anaemia in pregnancy: Lessons from a national audit.
    Br J Haematol. 2022;199:277-284.
    PubMed     Abstract available


  20. LECORNEC N, Castex MP, Reguerre Y, Moreau P, et al
    Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: A retrospective study of the French DBA cohort.
    Br J Haematol. 2022;199:285-288.
    PubMed    


    September 2022
  21. WULFTANGE WJ, Kucukal E, Man Y, An R, et al
    Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
    Br J Haematol. 2022;198:893-902.
    PubMed     Abstract available


  22. CORNELISSEN HM, Musekwa EM, Glashoff RH, Esser M, et al
    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.
    Br J Haematol. 2022;198:875-886.
    PubMed     Abstract available


  23. ALIBERTI L, Gagliardi I, Gamberini MR, Ziggiotto A, et al
    Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
    Br J Haematol. 2022;198:903-911.
    PubMed     Abstract available


  24. ARITA K, Murakami J, Iwaki N, Hosono N, et al
    An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
    Br J Haematol. 2022;198:e75-e77.
    PubMed    


  25. PATEL NG, Young D, Numan Y, Bhasin A, et al
    The utility of peripheral blood film and haemolysis markers in evaluation of haemolytic anaemia at a tertiary care hospital.
    Br J Haematol. 2022;198:927-929.
    PubMed    


  26. VERCELLATI C, Zaninoni A, Marcello AP, Fermo E, et al
    Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years.
    Br J Haematol. 2022;198:912-915.
    PubMed     Abstract available


  27. TANTRAVAHI SK, Huber BD, Vagher J, Maese L, et al
    Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
    Br J Haematol. 2022;198:e78-e81.
    PubMed    


  28. SONGDEJ D, Kadegasem P, Tangbubpha N, Sasanakul W, et al
    Whole-exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes.
    Br J Haematol. 2022;198:1051-1064.
    PubMed     Abstract available


    August 2022
  29. WILSON J
    Unlikely bedfellows - Sickle cells with malaria parasites.
    Br J Haematol. 2022 Aug 12. doi: 10.1111/bjh.18412.
    PubMed    


  30. MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
    Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Br J Haematol. 2022;198:574-586.
    PubMed     Abstract available


  31. ROY NBA, Da Costa L, Russo R, Bianchi P, et al
    The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
    Br J Haematol. 2022;198:459-477.
    PubMed    


  32. NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
    Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
    Br J Haematol. 2022;198:e46-e50.
    PubMed    


  33. GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
    Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
    Br J Haematol. 2022;198:e42-e45.
    PubMed    


  34. GREEN NS, Van Doren L, Licursi M, Billings DD, et al
    Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
    Br J Haematol. 2022;198:680-683.
    PubMed    


  35. SHARMA A, Leonard A, West K, Gossett JM, et al
    Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
    Br J Haematol. 2022;198:740-744.
    PubMed     Abstract available


  36. URSULE-DUFAIT C, Bengoufa D, Theodorou I, Villesuzanne C, et al
    Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease.
    Br J Haematol. 2022;198:e67-e70.
    PubMed    


  37. OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
    Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Br J Haematol. 2022;198:745-752.
    PubMed     Abstract available


  38. GELBENEGGER G, Jaeger U, Fillitz M, D'Sa S, et al
    Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
    Br J Haematol. 2022;198:e59-e62.
    PubMed    


    July 2022
  39. SCOTT C, Bartolovic K, Clark SA, Waithe D, et al
    Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
    Br J Haematol. 2022;198:e10-e14.
    PubMed    


  40. COOPER-SOOD JB, Hagar W, Marsh A, Hoppe C, et al
    Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
    Br J Haematol. 2022;198:207-209.
    PubMed    


  41. BUESCHE G, Teoman H, Schneider RK, Ribezzo F, et al
    Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
    Br J Haematol. 2022;198:114-130.
    PubMed     Abstract available


  42. CAUGHEY MC, Derebail VK, Carden MA, Novelli EM, et al
    Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.
    Br J Haematol. 2022;198:397-400.
    PubMed    


  43. GUO JJ, Cao L, Zhu HY, Miao Y, et al
    T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases.
    Br J Haematol. 2022;198:e18-e22.
    PubMed    


  44. KONGKIATKAMON S
    Acute haemolysis following COVID-19 vaccination in a thalassaemic patient with G6PD deficiency.
    Br J Haematol. 2022;198:221.
    PubMed    


  45. EARLY ML, Linton E, Bosch A, Campbell T, et al
    The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.
    Br J Haematol. 2022;198:382-390.
    PubMed     Abstract available


    June 2022
  46. DELAPORTA P, Terpos E, Solomou EE, Gumeni S, et al
    Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2022;197:576-579.
    PubMed     Abstract available


  47. PICCIN A, O'Connor-Byrne N, Daves M, Lynch K, et al
    Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'.
    Br J Haematol. 2022;197:518-528.
    PubMed     Abstract available


  48. HAN J, Molokie RE, Hussain F, Njoku F, et al
    Voxelotor and albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2022;197:e63-e64.
    PubMed    


  49. SHEEHAN VA, van Beers EJ, Connes P, van Wijk R, et al
    Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:e61-e62.
    PubMed    


  50. JOLY P, Boisson C, Renoux C, Caillat N, et al
    Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia.
    Br J Haematol. 2022;197:e56-e58.
    PubMed    


  51. NARDO-MARINO A, Petersen J, Brewin JN, Birgens H, et al
    Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
    Br J Haematol. 2022;197:609-617.
    PubMed     Abstract available


  52. MARSHALL WH 5TH, Cleary EM, Della-Moretta S, Li R, et al
    Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
    Br J Haematol. 2022;197:795-801.
    PubMed    


    May 2022
  53. AMID A, Barrowman N, Odame I, Kirby-Allen M, et al
    Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
    Br J Haematol. 2022;197:373-376.
    PubMed     Abstract available


  54. LONGORIA JN, Heitzer AM, Hankins JS, Trpchevska A, et al
    Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Br J Haematol. 2022;197:260-270.
    PubMed     Abstract available


  55. BAIN BJ, Littlewood T, Rees DC
    What does the term 'sickle cell disease' mean?
    Br J Haematol. 2022;197:381-382.
    PubMed    


  56. ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
    Fanconi anaemia: A syndrome with distinct subgroups.
    Br J Haematol. 2022;197:467-474.
    PubMed     Abstract available


  57. VORA SM, Boyd S, Denny N, Jackson E, et al
    Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
    Br J Haematol. 2022;197:502-504.
    PubMed    


    April 2022
  58. TANIGUCHI T, Nakayama S, Tanaka H, Rai S, et al
    Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
    Br J Haematol. 2022 Apr 22. doi: 10.1111/bjh.18208.
    PubMed     Abstract available


  59. SUN Y, Habara A, Le CQ, Nguyen N, et al
    Pharmacologic induction of PGC-1alpha stimulates fetal haemoglobin gene expression.
    Br J Haematol. 2022;197:97-109.
    PubMed     Abstract available


  60. RIEU JB, Largeaud L, Da Costa L, Cougoul P, et al
    Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors.
    Br J Haematol. 2022;197:132.
    PubMed    


  61. ROSS DM
    Iron chelation for myelofibrosis-related anaemia during treatment with a Janus kinase inhibitor.
    Br J Haematol. 2022;197:135-136.
    PubMed    


  62. GARG M, Agarwal S, Altohami M
    A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
    Br J Haematol. 2022;197:e28-e31.
    PubMed    


  63. BATISTA THC, Santana RM, Sobreira MJ, Arcanjo GS, et al
    Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia.
    Br J Haematol. 2022;197:e16-e18.
    PubMed    


  64. TORRES LS, Teles LIM, Shaul ME, Fridlender ZG, et al
    Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
    Br J Haematol. 2022;197:232-235.
    PubMed    


    March 2022
  65. MIODOWNIK H, Curtis SA, Olivia Ogu U, Bradford C, et al
    Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease.
    Br J Haematol. 2022;196:e41-e44.
    PubMed    


  66. CECCHI N, Giannotta JA, Barcellini W, Fattizzo B, et al
    A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Br J Haematol. 2022;196:1334-1336.
    PubMed    


  67. CONSTANTINOU V, Papayanni PG, Mallouri D, Batsis I, et al
    Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent beta-thalassaemia of a severe genotype.
    Br J Haematol. 2022;196:1401-1404.
    PubMed    


  68. CHARNAY T, Cerino M, Gonnet K, Bonello-Palot N, et al
    A novel SUPT5H variant associated with a beta-thalassaemia trait.
    Br J Haematol. 2022;196:e70-e71.
    PubMed    


  69. TAMURA S, Hori Y, Hiroi T, Morimoto M, et al
    Pegcetacoplan for refractory paroxysmal nocturnal haemoglobinuria associated with the C5 genetic variant.
    Br J Haematol. 2022;196:e57-e60.
    PubMed    


    February 2022
  70. RUND D
    Laboratory diagnosis of iron deficiency: look out for the 'PITTs'.
    Br J Haematol. 2022;196:464-465.
    PubMed    


  71. XU LP, Yu Y, Cheng YF, Zhang YY, et al
    Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
    Br J Haematol. 2022;196:735-742.
    PubMed     Abstract available


  72. FLETCHER A, Forbes A, Svenson N, Wayne Thomas D, et al
    Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
    Br J Haematol. 2022;196:523-529.
    PubMed    


  73. POPLAWSKA M, Dutta D, Jayaram M, Salifu M, et al
    Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease.
    Br J Haematol. 2022;196:777-780.
    PubMed     Abstract available


  74. GERRITSMA J, Bongaerts V, Eckhardt C, Heijboer H, et al
    Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Br J Haematol. 2022;196:769-776.
    PubMed     Abstract available


  75. BARADE A, Aboobacker F, Korula A, Lakshmi K, et al
    Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
    Br J Haematol. 2022;196:724-734.
    PubMed     Abstract available


  76. MAGGIO A
    Cell erythroid maturation approach: a new paradigm in the road map towards a cure for beta-thalassaemia syndromes.
    Br J Haematol. 2022;196:806-808.
    PubMed    


  77. OAKLEY LL, Mitchell S, von Rege I, Hadebe R, et al
    Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
    Br J Haematol. 2022;196:1069-1075.
    PubMed     Abstract available


  78. VLACHODIMITROPOULOU E, Garbowski M, Anne Solomon S, Abbasi N, et al
    Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Br J Haematol. 2022;196:1096-1104.
    PubMed     Abstract available


  79. JONASSAINT CR, Lukombo I, Feldman R, Driscoll J, et al
    Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
    Br J Haematol. 2022;196:1059-1068.
    PubMed     Abstract available


  80. WHITE J, Callaghan MU, Gao X, Liu K, et al
    Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    Br J Haematol. 2022;196:1052-1058.
    PubMed     Abstract available


  81. TANEJA K, Verma C, Mahajan A
    Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
    Br J Haematol. 2022;196:1111-1113.
    PubMed    


  82. VENUGOPAL J, Wang J, Guo C, Eitzman DT, et al
    Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
    Br J Haematol. 2022;196:1040-1051.
    PubMed     Abstract available


    January 2022
  83. NAVILLE AS, Lazaro E, Boutin J, Prot-Leurent C, et al
    Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.
    Br J Haematol. 2022 Jan 6. doi: 10.1111/bjh.18037.
    PubMed    


  84. BRODSKY RA, Lee JW, Nishimura JI, Szer J, et al
    Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?
    Br J Haematol. 2022;196:264-265.
    PubMed    


  85. RUND D
    A Paradigm shift in genotype-phenotype relationships in beta-thalassaemia.
    Br J Haematol. 2022;196:270-271.
    PubMed    


  86. ROY NBA
    Iron overload in inherited anaemias: why one size can't fit all.
    Br J Haematol. 2022;196:266-267.
    PubMed    


  87. SMITH WR, McClish DK, Lottenberg R, Sisler IY, et al
    A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
    Br J Haematol. 2022;196:193-203.
    PubMed     Abstract available


  88. CHAPIN J, Cohen AR, Neufeld EJ, Vichinsky E, et al
    An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
    Br J Haematol. 2022;196:380-389.
    PubMed     Abstract available


  89. MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
    Primary HBB gene mutation severity and long-term outcomes in a global cohort of beta-thalassaemia.
    Br J Haematol. 2022;196:414-423.
    PubMed     Abstract available


  90. SHAH FT, Porter JB, Sadasivam N, Kaya B, et al
    Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
    Br J Haematol. 2022;196:336-350.
    PubMed    


  91. CHEN N, Li Z, Huang Y, Xiao C, et al
    Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnan
    Br J Haematol. 2022;196:390-396.
    PubMed     Abstract available


  92. KIENZLE SL, Rodeghier M, Liem RI
    Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
    Br J Haematol. 2022;196:397-401.
    PubMed     Abstract available


  93. ADEBAYO OC, Betukumesu DK, Nkoy AB, Adesoji OM, et al
    Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
    Br J Haematol. 2022;196:204-214.
    PubMed     Abstract available


  94. GRIFFIN R, Panayiotou A, Allen P, Height S, et al
    What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
    Br J Haematol. 2022;196:402-413.
    PubMed     Abstract available


  95. COLMAN KS, Pavord S, Roy N
    A quality improvement project for the cost-effective management of maternal anaemia.
    Br J Haematol. 2022;196:445-448.
    PubMed    


  96. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Galacteros F, et al
    Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
    Br J Haematol. 2022;196:183-192.
    PubMed     Abstract available


  97. RISITANO AM, Peffault de Latour R
    How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
    Br J Haematol. 2022;196:288-303.
    PubMed     Abstract available


  98. DEXTER D, McGann PT
    Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Br J Haematol. 2022;196:63-69.
    PubMed     Abstract available


  99. MANABE M, Hagiwara Y, Asada R, Tanizawa N, et al
    Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
    Br J Haematol. 2022;196:7.
    PubMed    


  100. BARRITEAU CM, Chiu A, Rodeghier M, Liem RI, et al
    Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
    Br J Haematol. 2022;196:179-182.
    PubMed     Abstract available


  101. HUGHES AD, Kurre P
    The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
    Br J Haematol. 2022;196:274-287.
    PubMed     Abstract available


  102. GABELLI M, Ademokun C, Cooper N, Amrolia PI, et al
    Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
    Br J Haematol. 2022;196:45-62.
    PubMed     Abstract available


    December 2021
  103. AOUN SA, Motabi I
    Cold agglutinin disease after COVID-19 vaccine.
    Br J Haematol. 2021;195:650.
    PubMed    


  104. LIN J, Ye Y, Shang X, Zhang Y, et al
    TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the gamma-globin gene promoters.
    Br J Haematol. 2021;195:764-769.
    PubMed     Abstract available


  105. NAKAGAWA N, Ishiyama K, Tanabe M, Yoroidaka T, et al
    The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
    Br J Haematol. 2021;195:770-780.
    PubMed     Abstract available


  106. BADAWY SM, Payne AB, Hulihan MM, Coates TD, et al
    Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Cont
    Br J Haematol. 2021;195:e160-e164.
    PubMed    


  107. WILSON SR, Sears M, Williams E, Drapekin J, et al
    Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Br J Haematol. 2021;195:e157-e160.
    PubMed    


    November 2021
  108. HALL R, Meenan J, Mihalca D, Katumba A, et al
    The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
    Br J Haematol. 2021;195:532-535.
    PubMed    


  109. LILES DK, Shah NR, Scullin B, Gordeuk VR, et al
    Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
    Br J Haematol. 2021;195:e150-e153.
    PubMed    


  110. EL-AMIN N, Lauzon SD, Nietert PJ, Kanter J, et al
    Which adults with sickle cell disease need an evaluation for pulmonary embolism?
    Br J Haematol. 2021;195:447-455.
    PubMed     Abstract available


  111. WANG W, Freeman M, Hamilton L, Carroll Y, et al
    Developmental screening of three-year-old children with sickle cell disease compared to controls.
    Br J Haematol. 2021;195:621-628.
    PubMed     Abstract available


  112. BOISSON C, Renoux C, Nader E, Gauthier A, et al
    Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without alpha-thalassaemia.
    Br J Haematol. 2021;195:629-633.
    PubMed     Abstract available


  113. LAFAURIE M, Maquet J, Baricault B, Ekstrand C, et al
    Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Br J Haematol. 2021;195:456-465.
    PubMed     Abstract available


  114. RANKINE-MULLINGS A, Reid M, Soares D, Taylor-Bryan C, et al
    Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
    Br J Haematol. 2021;195:612-620.
    PubMed     Abstract available


  115. BALLAS SK, Kuypers FA, Gordeuk VR, Hankins JS, et al
    Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Br J Haematol. 2021;195:518-522.
    PubMed     Abstract available


    October 2021
  116. HE Z, Sun X, Wang S, Bai D, et al
    Ggct (gamma-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
    Br J Haematol. 2021;195:267-275.
    PubMed     Abstract available


  117. KARKOSKA K
    Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.
    Br J Haematol. 2021;195:158-159.
    PubMed    


  118. CAPPELLI B, Scigliuolo GM, Boukouaci W, Rafii H, et al
    Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
    Br J Haematol. 2021;195:e128-e131.
    PubMed    


  119. HEITZER AM, Longoria J, Okhomina V, Wang WC, et al
    Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
    Br J Haematol. 2021;195:256-266.
    PubMed     Abstract available


  120. DEREBAIL VK, Zhou Q, Ciccone EJ, Cai J, et al
    Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
    Br J Haematol. 2021;195:123-132.
    PubMed     Abstract available


    September 2021
  121. MASLAH N, Ravdan O, Drevon L, Verger E, et al
    Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
    PubMed     Abstract available


  122. BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
    COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
    Br J Haematol. 2021;194:854-856.
    PubMed    


  123. MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
    Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
    Br J Haematol. 2021;194:851-854.
    PubMed    


  124. HINES PC, Callaghan MU, Zaidi AU, Gao X, et al
    Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Br J Haematol. 2021;194:1074-1082.
    PubMed     Abstract available


  125. OTENG-NTIM E, Pavord S, Howard R, Robinson S, et al
    Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.
    Br J Haematol. 2021;194:980-995.
    PubMed    


  126. STRATTON P
    Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines.
    Br J Haematol. 2021;194:950-953.
    PubMed    


  127. GAARTMAN AE, Sayedi AK, Gerritsma JJ, de Back TR, et al
    Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
    Br J Haematol. 2021;194:899-907.
    PubMed     Abstract available


  128. PECKER LH, Sharma D, Nero A, Paidas MJ, et al
    Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.
    Br J Haematol. 2021;194:970-979.
    PubMed     Abstract available


  129. RIEGER MJ, Stolz SM, Ludwig S, Benoit TM, et al
    Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
    Br J Haematol. 2021;194:931-934.
    PubMed    


  130. BOUDHABHAY I, Boutin E, Bartolucci P, Bornes MI, et al
    Impact of pre-eclampsia on renal outcome in sickle cell disease patients.
    Br J Haematol. 2021;194:1053-1062.
    PubMed     Abstract available


  131. MALINOWSKI AK, Kuo KHM, Tomlinson GA, Palcu P, et al
    Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Br J Haematol. 2021;194:1063-1073.
    PubMed     Abstract available


  132. SARAF SL
    The vasculopathic cord between pre-eclampsia and kidney function in sickle cell disease.
    Br J Haematol. 2021;194:947-949.
    PubMed    


  133. KUMKHAEK C, Uchida N, Tisdale JF, Rodgers GP, et al
    Comparison of CD34(+) cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late-stage erythroid differentiation.
    Br J Haematol. 2021;194:e80-e84.
    PubMed    


  134. GOTTGENS EL, Ligthart PC, Veldhuisen B, Veldthuis M, et al
    Rh-null phenotype and stomatocytosis.
    Br J Haematol. 2021;194:803.
    PubMed    


  135. SCHEINBERG P
    Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
    Br J Haematol. 2021;194:954-969.
    PubMed     Abstract available


    August 2021
  136. NJOKU F, Zhang X, Shah BN, Machado RF, et al
    Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.
    Br J Haematol. 2021;194:767-778.
    PubMed     Abstract available


  137. ELSHERIF L, Scott LC, Wichlan D, Jones SK, et al
    Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
    Br J Haematol. 2021;194:e71-e73.
    PubMed    


  138. QUINN CT, Niss O, Dong M, Pfeiffer A, et al
    Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Br J Haematol. 2021;194:617-625.
    PubMed     Abstract available


  139. TANGSRICHAROEN T, Natesirinilkul R, Phusua A, Fanhchaksai K, et al
    Severe neonatal haemolytic anaemia caused by compound heterozygous KLF1 mutations: report of four families and literature review.
    Br J Haematol. 2021;194:626-634.
    PubMed     Abstract available


    July 2021
  140. FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
    Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
    Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
    PubMed    


  141. KILLICK SB, Ingram W, Culligan D, Enright H, et al
    British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
    Br J Haematol. 2021;194:267-281.
    PubMed    


  142. MITTELMAN M, Oster HS
    Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?
    Br J Haematol. 2021;194:231-233.
    PubMed    


  143. RASHKIN SR, Rampersaud E, Kang G, Ataga KI, et al
    Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.
    Br J Haematol. 2021;194:469-473.
    PubMed     Abstract available


  144. ESTEPP JH, Cong Z, Agodoa I, Kang G, et al
    What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
    Br J Haematol. 2021;194:463-468.
    PubMed     Abstract available


  145. ALNAFIE AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, et al
    Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease.
    Br J Haematol. 2021;194:e61-e64.
    PubMed    


  146. PERES L, Monedero Alonso D, Nudel M, Figeac M, et al
    Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
    Br J Haematol. 2021;194:e51-e55.
    PubMed    


  147. VADOLAS J, Ng GZ, Kysenius K, Crouch PJ, et al
    SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia.
    Br J Haematol. 2021;194:200-210.
    PubMed     Abstract available


  148. TAHER AT, Viprakasit V, Cappellini MD, Kraus D, et al
    Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2021;194:474-477.
    PubMed    


  149. WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
    The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
    Br J Haematol. 2021;194:e56-e58.
    PubMed    


  150. TAMAGNE M, Pakdaman S, Bartolucci P, Habibi A, et al
    Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization.
    Br J Haematol. 2021;194:477-481.
    PubMed    


  151. RIEU JB, El Kassir A, Largeaud L, Dion J, et al
    Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome.
    Br J Haematol. 2021;194:8.
    PubMed    


  152. WARE RE, Dertinger SD
    Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
    Br J Haematol. 2021;194:252-266.
    PubMed     Abstract available


  153. PACE BS, Starlard-Davenport A, Kutlar A
    Sickle cell disease: progress towards combination drug therapy.
    Br J Haematol. 2021;194:240-251.
    PubMed     Abstract available


    June 2021
  154. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    PubMed    


  155. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    PubMed    


  156. STEINBERG MH
    HbA2 induction: the merit of pancellularity in sickle cell disease.
    Br J Haematol. 2021;193:1032-1033.
    PubMed    


  157. HILLS RK
    Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
    Br J Haematol. 2021;193:1030-1031.
    PubMed    


  158. BLAISE D, Savani BN
    Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
    Br J Haematol. 2021;193:863-864.
    PubMed    


  159. PORCU S, Simbula M, Marongiu MF, Perra A, et al
    Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Br J Haematol. 2021;193:1228-1237.
    PubMed     Abstract available


  160. VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
    Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
    Br J Haematol. 2021;193:1185-1193.
    PubMed     Abstract available


  161. LIANG Y, Zhang X, Liu Y, Wang L, et al
    GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
    Br J Haematol. 2021;193:1220-1227.
    PubMed     Abstract available


  162. CHILDS RW, Tian X, Vo P, Purev E, et al
    Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2021;193:951-960.
    PubMed     Abstract available


  163. MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
    Transfusion management of severe anaemia in African children: a consensus algorithm.
    Br J Haematol. 2021;193:1247-1259.
    PubMed     Abstract available


  164. LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
    Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Br J Haematol. 2021;193:994-1000.
    PubMed     Abstract available


  165. JANG T, Mo G, Stewart C, Egini O, et al
    Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
    Br J Haematol. 2021;193:1281-1283.
    PubMed    


  166. MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
    Deficient mitophagy pathways in sickle cell disease.
    Br J Haematol. 2021;193:988-993.
    PubMed     Abstract available


  167. XU Y, Alfaro-Magallanes VM, Babitt JL
    Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
    Br J Haematol. 2021;193:882-893.
    PubMed     Abstract available


  168. JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
    Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
    Br J Haematol. 2021;193:971-975.
    PubMed     Abstract available


    May 2021
  169. UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
    Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
    Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
    PubMed     Abstract available


  170. BARCELLINI W, Colombatti R
    The impact of Parvovirus B19 on hereditary haemolytic anaemias.
    Br J Haematol. 2021;193:703-704.
    PubMed    


  171. BOOTH GS, Savani BN, Langston AA
    Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
    Br J Haematol. 2021;193:701-702.
    PubMed    


  172. ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
    Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
    Br J Haematol. 2021;193:827-840.
    PubMed     Abstract available


  173. LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
    Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
    Br J Haematol. 2021;193:814-826.
    PubMed     Abstract available


  174. VINCHI F, Sparla R, Passos ST, Sharma R, et al
    Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
    Br J Haematol. 2021;193:637-658.
    PubMed     Abstract available


  175. RUND D
    Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
    Br J Haematol. 2021;193:466-480.
    PubMed     Abstract available


  176. SARAF SL, Zhang X, Shah BN, Raslan R, et al
    Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
    Br J Haematol. 2021;193:628-632.
    PubMed     Abstract available


  177. DENTON CC, Detterich JA, Coates TD, Wood JC, et al
    Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
    Br J Haematol. 2021;193:633-636.
    PubMed     Abstract available


    April 2021
  178. BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
    Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
    Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
    PubMed     Abstract available


  179. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    PubMed    


  180. BENNETT R, Ruskova A
    Atezolizumab-induced pure red cell aplasia.
    Br J Haematol. 2021;193:10.
    PubMed    


  181. LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
    The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
    Br J Haematol. 2021;193:26-42.
    PubMed     Abstract available


  182. SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
    Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
    Br J Haematol. 2021;193:415-419.
    PubMed    


  183. CHENG Y, Shang X, Chen D, Pang D, et al
    MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
    Br J Haematol. 2021;193:401-405.
    PubMed     Abstract available


  184. QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
    Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
    Br J Haematol. 2021;193:410-414.
    PubMed     Abstract available


    March 2021
  185. SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
    Cognitive performance as a predictor of healthcare transition in sickle cell disease.
    Br J Haematol. 2021;192:1082-1091.
    PubMed     Abstract available


  186. AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
    The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol. 2021;192:1092-1096.
    PubMed     Abstract available


  187. EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
    Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
    Br J Haematol. 2021;192:909-921.
    PubMed     Abstract available


  188. ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
    Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
    Br J Haematol. 2021;192:e129-e132.
    PubMed    


  189. OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
    Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
    Br J Haematol. 2021;192:e127-e129.
    PubMed    


  190. SACHDEV V, Tian X, Gu Y, Nichols J, et al
    A phenotypic risk score for predicting mortality in sickle cell disease.
    Br J Haematol. 2021;192:932-941.
    PubMed     Abstract available


  191. RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
    Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
    Br J Haematol. 2021;192:922-931.
    PubMed     Abstract available


    February 2021
  192. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    PubMed    


  193. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    PubMed    


  194. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    PubMed     Abstract available


  195. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    PubMed     Abstract available


  196. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    PubMed     Abstract available


  197. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    PubMed    


  198. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    PubMed     Abstract available


  199. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    PubMed     Abstract available


  200. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    PubMed     Abstract available


    January 2021
  201. KULASEKARARAJ AG, Marsh JCW
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    PubMed    


  202. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    PubMed     Abstract available



  203. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    PubMed    


  204. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    PubMed    


  205. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    PubMed     Abstract available


  206. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    PubMed     Abstract available


  207. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    PubMed     Abstract available


  208. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    PubMed     Abstract available


  209. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    PubMed    


  210. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    PubMed     Abstract available


  211. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    PubMed     Abstract available


    December 2020
  212. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    PubMed    


  213. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    PubMed     Abstract available


  214. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    PubMed     Abstract available


  215. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    PubMed    


  216. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    PubMed     Abstract available


  217. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    PubMed     Abstract available


  218. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    PubMed     Abstract available


    November 2020
  219. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    PubMed     Abstract available


  220. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    PubMed    


  221. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    PubMed    


  222. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    PubMed    


  223. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    PubMed    


  224. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    PubMed     Abstract available


  225. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    PubMed     Abstract available


    October 2020
  226. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    PubMed    


  227. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    PubMed    


  228. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    PubMed    


  229. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    PubMed    


  230. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    PubMed    


  231. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    PubMed     Abstract available


  232. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    PubMed     Abstract available


    September 2020
  233. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    PubMed    


  234. OLATUNYA OS
    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    PubMed    


  235. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    PubMed    


  236. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    PubMed    


  237. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    PubMed    


  238. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    PubMed    


  239. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    PubMed    


  240. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    PubMed     Abstract available


    August 2020
  241. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    PubMed    


  242. KULASEKARARAJ AG
    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    PubMed    


  243. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    PubMed    


  244. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    PubMed    


  245. MALINOWSKI AK
    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    PubMed    


  246. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    PubMed    


  247. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    PubMed    


  248. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    PubMed    


  249. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    PubMed    


  250. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    PubMed    


  251. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    PubMed     Abstract available


  252. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    PubMed     Abstract available


  253. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    PubMed     Abstract available


  254. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    PubMed     Abstract available


  255. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    PubMed     Abstract available


    July 2020
  256. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    PubMed    


  257. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    PubMed    


  258. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    PubMed     Abstract available


  259. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    PubMed     Abstract available


  260. KATTAMIS A
    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    PubMed    


  261. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    PubMed     Abstract available


  262. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    PubMed     Abstract available


    June 2020
  263. LUZZATTO L
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    PubMed    


  264. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    PubMed    


  265. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    PubMed    


  266. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    PubMed    


  267. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    PubMed    


  268. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    PubMed     Abstract available


  269. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    PubMed     Abstract available


  270. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    PubMed    


  271. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    PubMed     Abstract available


  272. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    PubMed     Abstract available


  273. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    PubMed     Abstract available


    May 2020
  274. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    PubMed    


  275. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    PubMed    


  276. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    PubMed    


  277. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    PubMed    


  278. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    PubMed     Abstract available


  279. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    PubMed     Abstract available


  280. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    PubMed     Abstract available


    April 2020
  281. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    PubMed    


  282. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    PubMed    


  283. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    PubMed    


  284. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    PubMed     Abstract available


  285. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    PubMed     Abstract available


  286. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    PubMed     Abstract available


  287. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    PubMed    


    March 2020
  288. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    PubMed    


  289. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    PubMed     Abstract available


  290. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    PubMed     Abstract available


  291. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    PubMed    


  292. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    PubMed     Abstract available


  293. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: